Environmental agents and autoimmune diseases

Advances in Experimental Medicine and Biology

Volumn 711, Issue , 2011, Pages 61-81

  Miller, Frederick W ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ALPHA INTERFERON; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; BERYLLIUM; BETA INTERFERON; BLEOMYCIN; CADMIUM; CAPTOPRIL; CD70 ANTIGEN; CHLORPROMAZINE; ESTROGEN DERIVATIVE; GAMMA INTERFERON; GOLD SALT; HEAVY METAL; HYDRALAZINE; INTERLEUKIN 2; ISONIAZID; MERCURY; METHYLDOPA; PENICILLAMINE; PENICILLIN G; PESTICIDE; PHENYTOIN; PROCAINAMIDE; SILICON DIOXIDE; SOLVENT; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VACCINE;

ANTIGEN EXPRESSION; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CAUSAL ATTRIBUTION; CIGARETTE SMOKING; DIETARY INTAKE; DISEASE COURSE; DRUG USE; ENVIRONMENTAL DISEASE; ENVIRONMENTAL EXPOSURE; GENE FREQUENCY; GENETIC RISK; GOODPASTURE SYNDROME; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; HYPOTHYROIDISM; IMMUNE RESPONSE; LUPUS LIKE SYNDROME; MEMBRANOUS GLOMERULONEPHRITIS; MYOSITIS; OCCUPATIONAL EXPOSURE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCLERODERMA; SILICONE PROSTHESIS; T LYMPHOCYTE; THROMBOCYTOPENIA; ULTRAVIOLET RADIATION; VASCULITIS; ANIMAL; ENVIRONMENT; GENETICS; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; HUMANS; RISK FACTORS;

EID: 79958265756     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8216-2_6     Document Type: Article

References (93)

1. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347(12):911-920.
2. WHO Task Group on Environmental Health Criteria. Environmental Health Criteria 236. Principles and Methods for Assessing Autoimmunity Associated with Exposure to Chemicals. 236, 1-324. 2006. WHO Report.
3. NIH Autoimmune Diseases Coordinating Committee. NIH Autoimmune Diseases Research Plan. 1-83. 2002. U.S. Department of Health and Human Services Report.
4. National Institutes of Health Autoimmune Diseases Coordinating Committee. Progress in Autoimmune Diseases Research. 1-126. 2005. Bethesda, NIH Report. NIH Publication No. 05-5140.
5. Gourley M, Miller FW. Mechanisms of disease: Environmental factors in the pathogenesis of rheumatic disease. Nat Clin Pract Rheumatol 2007; 3(3):172-180. (Pubitemid 46416266)
6. Gregersen PK, Olsson LM. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 2009; 27:363-391.
7. Gregersen PK. Modern genetics, ancient defenses and potential therapies. N Engl J Med 2007; 356(12):1263-1266. (Pubitemid 46465605)
8. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009.
9. Sarasin A. An overview of the mechanisms of mutagenesis and carcinogenesis. Mutat Res 2003; 544(2-3):99-106. (Pubitemid 37487653)
10. Cooper GS, Miller FW, Germolec DR. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2002; 2(2-3):303-313. (Pubitemid 34075419)
11. Miller FW, Twitty SA, Biswas T et al. Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability and isotype restriction of anti-Jo-1 autoantibodies. J Clin Invest 1990; 85(2):468-475. (Pubitemid 20070054)
12. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349(16):1526-1533. (Pubitemid 37255038)
13. Kokkonen H, Soderstrom I, Rocklov J et al. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 2010; 62(2):383-391.
14. Cooper GS, Miller FW, Pandey JP. The Role of Genetic Factors in Autoimmune Disease: Implications for Environmental Research. Environ Health Perspect 1999; 107(Suppl 5):693-700. (Pubitemid 29527772)
15. Leslie RD, Hawa M. Twin studies in auto-immune disease. Acta Genet Med Gemellol (Roma) 1994; 43:71-81. (Pubitemid 24305877)
16. Miller FW, Hess EV, Clauw DJ et al. Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 2000; 43(2):243-249.
17. Samuelsson U, Carstensen J. Space-time clustering at birth and at diagnosis of type 1 diabetes mellitus in relation to early clinical manifestation. J Pediatr Endocrinol Metab 2003; 16(6):859-867. (Pubitemid 37259172)
18. LeffRL, Burgess SH, Miller FW et al. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum 1991; 34(11):1391-1396.
19. Sarkar K, Weinberg CR, Oddis CV et al. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum 2005; 52(8):2433-2438. (Pubitemid 41117429)
20. Willis JA, Scott RS, Darlow BA et al. Seasonality of birth and onset of clinical disease in children and adolescents (0-19 years) with type 1 diabetes mellitus in Canterbury, New Zealand. J Pediatr Endocrinol Metab 2002; 15(5):645-647. (Pubitemid 34704824)
21. Ursic-Bratina N, Battelino T, Krzisnik C et al. Seasonality of birth in children (0-14 years) with type 1 diabetes mellitus in Slovenia. J Pediatr Endocrinol Metab 2001; 14(1):47-52. (Pubitemid 32166451)
22. Haus E, Smolensky MH. Biologic rhythms in the immune system. Chronobiol Int 1999; 16(5):581-622. (Pubitemid 29463830)
23. Nelson RJ, Drazen DL. Melatonin mediates seasonal changes in immune function. Ann N Y Acad Sci 2000; 917:404-415.
24. Okada S, Weatherhead E, Targoff IN et al. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 2003; 48(8):2285-2293. (Pubitemid 36959210)
25. Love LA, Weinberg CR, McConnaughey R et al. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. arth and rheum. Arthritis Rheum. 2009; 60:2499-504
26. Ponsonby AL, McMichael A, van dM I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002; 181-182:71-78. (Pubitemid 36015675)
27. Oddis CV, Conte CG, Steen VD et al. Incidence ofpolymyositis- dermatomyositis: a 20-year study ofhospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990; 17:1329-1334. (Pubitemid 20382859)
28. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003; 2(3):119-125. (Pubitemid 37443848)
29. Onkamo P, Vaananen S, Karvonen M et al. Worldwide increase in incidence of Type I diabetes-the analysis of the data on published incidence trends. Diabetologia 1999; 42(12):1395-1403. (Pubitemid 30012309)
30. Uramoto KM, Michet CJ Jr, Thumboo J et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999; 42(1):46-50. (Pubitemid 29042569)
31. Jacobson DL, Gange SJ, Rose NR et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84(3):223-243. (Pubitemid 27398022)
32. Noseworthy JH, Lucchinetti C, Rodriguez M et al. Multiple sclerosis. N Engl J Med 2000; 343(13):938-952.
33. Dahlquist G. The aetiology of type 1 diabetes: an epidemiological perspective. Acta Paediatr Suppl 1998; 425:5-10. (Pubitemid 28478142)
34. Philen RM, Posada dlP, Hill RH et al. Epidemiology of the toxic oil syndrome. Arch Toxicol Suppl 1997; 19:41-52.
35. Sfriso P, Ghirardello A, Botsios C et al. Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 2009.
36. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol 2009; 155(1):1-15.
37. Poole BD, Templeton AK, Guthridge JM et al. Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. Autoimmun Rev 2009; 8(4):337-342.
38. Oguz F, Akdeniz C, Unuvar E et al. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J Paediatr Child Health 2002; 38(4):358-362. (Pubitemid 35024975)
39. Mamyrova G, Rider LG, Haagenson L et al. Parvovirus B19 and onset of juvenile dermatomyositis. JAMA 2005; 294(17):2170-2171. (Pubitemid 41571133)
40. Feng Y, Ke X, Ma R et al. Parallel detection of autoantibodies with microarrays in rheumatoid diseases. Clin Chem 2004; 50(2):416-422. (Pubitemid 38156384)
41. Palacios G, Druce J, Du L et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008; 358(10):991-998. (Pubitemid 351347098)
42. Wu W, Tang YW. Emerging molecular assays for detection and characterization of respiratory viruses. Clin Lab Med 2009; 29(4):673-693.
43. Hess EV, Mongey AB. Drug-related lupus. Bull Rheum Dis 1991; 40:1-8.
44. Parks CG, Conrad K, Cooper GS. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 1999; 107 Suppl 5:793-802. (Pubitemid 29527785)
45. Pollard KM, Hultman P, Kono DH. Toxicology of Autoimmune Diseases. Chem Res Toxicol 2010.
46. Bagenstose LM, Salgame P, Monestier M. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol Res 1999; 20(1):67-78. (Pubitemid 29401314)
47. gmon-Levin N, Paz Z, Israeli E et al. Vaccines and autoimmunity. Nat Rev Rheumatol 2009; 5(11):648-652.
48. Israeli E, gmon-Levin N, Blank M et al. Adjuvants and autoimmunity. Lupus 2009; 18(13):1217-1225.
49. Advisory Committee on Immunization Practices. Update: Vaccine Side Effects, Adverse Reactions, Contraindications and Precautions Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996; 45(RR-12):1-35.
50. Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence? Lancet 2003; 362(9396):1659-1666. (Pubitemid 37443537)
51. Tugwell P, Wells G, Peterson J et al. Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel. Arthritis Rheum 2001; 44(11):2477-2484. (Pubitemid 33049325)
52. Janowsky EC, Kupper LL, Hulka BS. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med 2000; 342(11):781-790. (Pubitemid 30151922)
53. Brown SL. Epidemiology of silicone-gel breast implants. Epidemiology 2002; 13(3 Suppl):S34-S39. (Pubitemid 34412064)
54. Brown SL, Langone JJ, Brinton LA. Silicone breast implants and autoimmune disease. J Am Med Womens Assoc 1998; 53(1):21-4, 40.
55. O'Hanlon T, Koneru B, Bayat E et al. Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops. Arthritis Rheum 2004; 50(11):3646-3650. (Pubitemid 39488692)
56. Cukier J, Beauchamp RA, Spindler JS et al. Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Int Med 1993; 118:920-928. (Pubitemid 23164128)
57. Levy Y, Rotman-Pikielny P, Ehrenfeld M et al. Silicone breast implantation-induced scleroderma: description of four patients and a critical review of the literature. Lupus 2009; 18(13):1226-1232.
58. Elenkov IJ, Chrousos GP. Stress, cytokine patterns and susceptibility to disease. Baillieres Best Pract Res Clin Endocrinol Metab 1999; 13(4):583-595. (Pubitemid 30315887)
59. Winsa B, Adami HO, Bergstrom R et al. Stressful life events and Graves' disease. Lancet 1991; 338(8781):1475-1479.
60. Luppi P, Rossiello MR, Faas S et al. Genetic background and environment contribute synergistically to the onset of autoimmune diseases. J Mol Med 1995; 73:381-393.
61. Dooley MA, Hogan SL. Environmental epidemiology and risk factors for autoimmune disease. Curr Opin Rheumatol 2003; 15(2):99-103. (Pubitemid 36250287)
62. Miller FW. Non-infectious Environmental Agents and Autoimmunity. In: Rose NR, Mackay IR, eds. The Autoimmune Diseases. 4 ed. New York: Elsevier; 2006:1297-1308.
63. Miller FW. Genetics of environmentally-associated rheumatic disease. In: Kaufman LD, Varga J, eds. Rheumatic Diseases and the Environment. London: Arnold Publishers; 1999:33-45.
64. Mintzer DM, Billet SN, Chmielewski L. Drug-induced hematologic syndromes. Adv Hematol 2009; 2009:495863.
65. Casciola-RosenLA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179(4):1317-1330. (Pubitemid 24091790)
66. Hall JC, Casciola-Rosen L, Rosen A. Altered structure of autoantigens during apoptosis. Rheum Dis Clin North Am 2004; 30(3):455-71, vii. Review. (Pubitemid 38916996)
67. Burd CJ, Kinyamu HK, Miller FW et al. UV radiation regulates Mi-2 through protein translation and stability. J Biol Chem 2008; 283(50):34976-34982.
68. Kuhn A, Beissert S. Photosensitivity in lupus erythematosus. Autoimmunity 2005; 38(7):519-529. (Pubitemid 43101786)
69. Klareskog L, Stolt P, Lundberg K et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54(1):38-46. (Pubitemid 43122184)
70. Strickland FM, Richardson BC. Epigenetics in human autoimmunity. Epigenetics in autoimmunity-DNA methylation in systemic lupus erythematosus and beyond. Autoimmunity 2008; 41(4):278-286.
71. Burdick LM, Somani N, Somani AK. Type I IFNs and their role in the development of autoimmune diseases. Expert Opin Drug Saf 2009; 8(4):459-472.
72. Scherer K, Spoerl D, Bircher AJ. Adverse drug reactions to biological response modifiers. J Dtsch Dermatol Ges 2010.
73. Cooper GS, Miller FW. Environmental influences on autoimmunity and autoimmune diseases. In: Luebke R, editor. Immunotoxicology and Immunopharmacology. Third ed. New York: CRC Press; 2007 p.437-454.
74. Shamim EA, Miller FW. Familial autoimmunity and the idiopathic inflammatory myopathies. Current Rheumatology Reports 2000; 2(2):201-211.
75. Galloway TS, Brown RJ, Browne MA et al. The ECOMAN project: A novel approach to defining sustainable ecosystem function. Mar Pollut Bull 2006; 53(1-4):186-194.
76. Sloan CD, Duell EJ, Shi X et al. Ecogeographic genetic epidemiology. Genet Epidemiol 2009; 33(4):281-289.
77. Bigazzi PE. Autoimmunity caused by xenobiotics. Toxicology 1997; 119(1):1-21. (Pubitemid 27144252)
78. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 2000; 112-113:421-432. (Pubitemid 30138154)
79. Love LA, Miller FW. Noninfectious environmental agents associated with myopathies. Curr Opin Rheumatol 1993; 5(6):712-718. (Pubitemid 24012202)
80. Hess EV. Environmental chemicals and autoimmune disease: cause and effect. Toxicology 2002; 181-182:65-70. (Pubitemid 36015674)
81. Volzke H, Werner A, Wallaschofski H et al. Occupational exposure to ionizing radiation is associated with autoimmune thyroid disease. J Clin Endocrinol Metab 2005; 90(8):4587-4592. (Pubitemid 41159347)
82. Stolt P, Bengtsson C, Nordmark B et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003; 62(9):835-841. (Pubitemid 37026493)
83. Krishnan E. Smoking, gender and rheumatoid arthritis-epidemiological clues to etiology. Results from the behavioral risk factor surveillance system. Joint Bone Spine 2003; 70(6):496-502. (Pubitemid 38029802)
84. Kallberg H, Padyukov L, Plenge RM et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22 and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 2007; 80(5):867-875. (Pubitemid 46668455)
85. Vestergaard P. Smoking and thyroid disorders-a meta-analysis. Eur J Endocrinol 2002; 146(2):153-161.
86. Timmer A. Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology. Dig Dis 2003; 21(2):91-104. (Pubitemid 37323489)
87. Costenbader KH, Karlson EW. Cigarette smoking and systemic lupus erythematosus: a smoking gun? Autoimmunity (Pubitemid 43101788)
88. Alaedini A, Green PH. Narrative review: celiac disease: understanding a complex autoimmune disorder. Ann Intern Med 2005; 142(4):289-298. (Pubitemid 40216246)
89. PattisonDJ, Symmons DP, Lunt Met al. Dietary riskfactorsforthe development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 2004; 50(12):3804-3812. (Pubitemid 39643927)
90. Dally A. The rise and fall of pink disease. Soc Hist Med 1997; 10(2):291-304. (Pubitemid 127458441)
91. Bigazzi PE. Autoimmunity and heavy metals. Lupus 1994; 3(6):449-453.
92. Fontenot AP, Kotzin BL. Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity. Tissue Antigens 2003; 62(6):449-458. (Pubitemid 37475993)
93. Bengtsson AA, Rylander L, Hagmar L et al. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 2002; 41(5):563-571. (Pubitemid 34567188)